Abstract:Background: Diabetic retinopathy (DR) is a common microvascular complication of diabetes mellitus (DM) and a significant cause of acquired blindness in the working-age population worldwide. Aging is considered as an important risk factor for DR development. Macrophages in aged mice bear typical M2 marker proteins but simultaneously express a pro-inflammatory factor profile. This may explain why the level of intraocular inflammation does not decrease during proliferative diabetic retinopathy (PDR) despite the occurrence of neovascularization and fibrosis (M2 activation). α-Klotho (KL) was originally discovered as a soluble anti-aging factor, which is mainly expressed in kidney tubular epithelium, choroid plexus in the brain and secreted in the blood. However, the role of KL in DR pathophysiology has not been previously reported. Methods: Type 1 (streptozotocin [STZ]-induced) and type 2 (a high-fat diet along with a low dose of STZ) diabetic mouse models were established and injected with or without KL adenovirus via the tail vein for 12 weeks. Vldlr-/- mice were injected intravitreally with or without soluble KL protein from P8 to P15. The retinal structure and function were analyzed by electroretinogram and optical coherence tomography. The neovascular lesions were analyzed by retinal flat mount and RPE flat mount. The senescence markers, macrophage morphology, and KL expression levels were detected by immunofluorescence staining. A cell model was constructed using RAW264.7 cells stimulated by 4-hydroxynonenal (4HNE) and transfected with or without KL adenovirus. The senescence-associated secretory phenotypes were detected by qRT-PCR. Senescence was detected by SA-β-Gal staining. Serum, aqueous humor, and vitreous humor KL levels of proliferative diabetic retinopathy (PDR) patients were measured by enzyme-linked immunosorbent assay. Quantitative proteomics and bioinformatics were applied to predict the change of proteins and biological function after overexpression of KL in macrophages. The effects of KL on the HECTD1 binding to IRS1 were analyzed by bioinformatics, molecular docking, and Western Blot. Results: Serum, aqueous humor, and vitreous humor KL levels were lower in patients with PDR than in those with cataracts. KL relieved the retinal structure damage, improved retina function, and inhibited retinal senescence in diabetic mice. KL administration attenuated the neovascular lesions in VLDLR-/- mice by decreasing the secretion of VEGFA and FGF2 from macrophages. KL also protected RAW264.7 cells from 4HNE-induced senescence. Additionally, it inhibited E3 ubiquitin ligase HECTD1 expression in both diabetic mouse peripheral blood mononuclear cells and 4HNE-treated RAW264.7 cells. KL inhibited HECTD1 binding to IRS1 and reduced the ubiquitination of IRS1. Conclusions: Macrophage aging is involved in DM-induced retinopathy. KL alleviates DM-induced retinal macrophage senescence by downregulating HECTD1 and decreasing IRS1 ubiquitination and degradation. Meanwhile, KL administration attenuated the neovascular lesions by altering the activation state of macrophages and decreasing the expression of VEGFA and FGF2.

Low-dose Phloretin Alleviates Diabetic Atherosclerosis Through Endothelial KLF2 Restoration

Phloretin Ameliorates Diabetes-Induced Endothelial Injury Through AMPK-dependent Anti-Endmt Pathway

Phloretin Ameliorates Diabetic Nephropathy by Inhibiting Nephrin and Podocin Reduction Through a Non-Hypoglycemic Effect

Endothelial KLF11 is a novel protector against diabetic atherosclerosis

A dual Keap1 and p47 phox inhibitor Ginsenoside Rb1 ameliorates high glucose/ox-LDL-induced endothelial cell injury and atherosclerosis

Protective effects of phloretin on rod photoreceptors in diabetic mice

Atherosclerosis is attenuated by acacetin via Sirt1-mediated activation of AMPK/Sirt3 signals in diabetic ApoE-/- mice

Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease <i>via</i> Inhibiting the mTORC1/SREBP-1c Pathway

Phloretin attenuation of hepatic steatosis <i>via</i> an improvement of mitochondrial dysfunction by activating AMPK-dependent signaling pathways in C57BL/6J mice and HepG2 cells

Phloretin Exerts Hypoglycemic Effect in Streptozotocin-Induced Diabetic Rats and Improves Insulin Resistance in Vitro

Phloretin promotes adipocyte differentiation in vitro and improves glucose homeostasis in vivo.

Activation of AMPK/Sirt3 Pathway by Phloretin Reduces Mitochondrial ROS in Vascular Endothelium by Increasing the Activity of MnSOD Via Deacetylation

Phloretin inhibits glucose transport and reduces inflammation in human retinal pigment epithelial cells

Effects of Phlorizin on Vascular Complications in Diabetes Db/db Mice.

Abstract 461: Enhanced Glycolysis in Endothelial Cells Protects Against Atherosclerosis

Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis Through Activation Of Nrf2 Signaling

Acacetin Protects Against High Glucose-Induced Endothelial Cells Injury by Preserving Mitochondrial Function via Activating Sirt1/Sirt3/AMPK Signals

Therapeutic Effects of Phlorizin on the Early Stage of Diabetic Retinopathy in Diabetic Db/db Mice

Phloretin Attenuates Hyperuricemia‐induced Endothelial Dysfunction Through Co‐inhibiting Inflammation and GLUT9‐mediated Uric Acid Uptake

α-Klotho prevents diabetic retinopathy by reversing the senescence of macrophages

DPHC From Alpinia officinarum Ameliorates Oxidative Stress and Insulin Resistance via Activation of Nrf2/ARE Pathway in db/db Mice and High Glucose-Treated HepG2 Cells